Table 5.

Follow-up of all women with no prior thyroid diagnosis when stratified by levels of thyrotropin receptor antibodies and thyrotropin in early pregnancy

TSH < 0.1 mIU/LTSH ≥ 0.1 mIU/L
TRAb > 1.0 IU/LTRAb ≤ 1.0 IU/LTRAb > 1.0 IU/LTRAb ≤ 1.0 IU/L
n = 21n = 393n = 26n = 542
nRF (%)95% CInRF (%)95% CInRF (%)95% CInRF (%)95% CI
Later hyperthyroid diagnosis1152.429.8-74.3338.45.9-11.6< 5N/AN/A< 5N/AN/A
Later ATD treatment1047.625.7-70.2174.32.5-6.8< 5N/AN/A< 5N/AN/A
Later thyroid surgery or radioiodine treatment< 5N/AN/A51.30.4-2.9< 5N/AN/A< 5N/AN/A
Later pregnancy942.921.8-66.015439.234.3-44.21142.323.4-63.127150.045.7-54.3
 Hyperthyroidism in pregnancy or 2 y post partuma523.88.2-47.2102.51.2-4.6< 5N/AN/A< 5N/AN/A
 ATD in pregnancy or 2 y post partumb523.88.2-47.251.30.4-2.9< 5N/AN/A< 5N/AN/A
TSH < 0.1 mIU/LTSH ≥ 0.1 mIU/L
TRAb > 1.0 IU/LTRAb ≤ 1.0 IU/LTRAb > 1.0 IU/LTRAb ≤ 1.0 IU/L
n = 21n = 393n = 26n = 542
nRF (%)95% CInRF (%)95% CInRF (%)95% CInRF (%)95% CI
Later hyperthyroid diagnosis1152.429.8-74.3338.45.9-11.6< 5N/AN/A< 5N/AN/A
Later ATD treatment1047.625.7-70.2174.32.5-6.8< 5N/AN/A< 5N/AN/A
Later thyroid surgery or radioiodine treatment< 5N/AN/A51.30.4-2.9< 5N/AN/A< 5N/AN/A
Later pregnancy942.921.8-66.015439.234.3-44.21142.323.4-63.127150.045.7-54.3
 Hyperthyroidism in pregnancy or 2 y post partuma523.88.2-47.2102.51.2-4.6< 5N/AN/A< 5N/AN/A
 ATD in pregnancy or 2 y post partumb523.88.2-47.251.30.4-2.9< 5N/AN/A< 5N/AN/A
Median95% CIMedian95% CI
No. of later ATD prescriptionsc134-2533-7
Median95% CIMedian95% CI
No. of later ATD prescriptionsc134-2533-7

Abbreviations: β-hCG, β-human chorionic gonadotropin; ATD, antithyroid drugs; BMI, body mass index; fT4, free thyroxine; N/A, not available; RF, relative frequency; TRAb, thyrotropin receptor antibodies; TSH, thyrotropin.

aHospital diagnosis of hyperthyroidism while pregnant or 2 years post partum.

bPrescription of ATD in the period from 1 month before pregnancy until 2 years post partum.

cNumber of prescriptions from the first prescription until December 31, 2020.

Table 5.

Follow-up of all women with no prior thyroid diagnosis when stratified by levels of thyrotropin receptor antibodies and thyrotropin in early pregnancy

TSH < 0.1 mIU/LTSH ≥ 0.1 mIU/L
TRAb > 1.0 IU/LTRAb ≤ 1.0 IU/LTRAb > 1.0 IU/LTRAb ≤ 1.0 IU/L
n = 21n = 393n = 26n = 542
nRF (%)95% CInRF (%)95% CInRF (%)95% CInRF (%)95% CI
Later hyperthyroid diagnosis1152.429.8-74.3338.45.9-11.6< 5N/AN/A< 5N/AN/A
Later ATD treatment1047.625.7-70.2174.32.5-6.8< 5N/AN/A< 5N/AN/A
Later thyroid surgery or radioiodine treatment< 5N/AN/A51.30.4-2.9< 5N/AN/A< 5N/AN/A
Later pregnancy942.921.8-66.015439.234.3-44.21142.323.4-63.127150.045.7-54.3
 Hyperthyroidism in pregnancy or 2 y post partuma523.88.2-47.2102.51.2-4.6< 5N/AN/A< 5N/AN/A
 ATD in pregnancy or 2 y post partumb523.88.2-47.251.30.4-2.9< 5N/AN/A< 5N/AN/A
TSH < 0.1 mIU/LTSH ≥ 0.1 mIU/L
TRAb > 1.0 IU/LTRAb ≤ 1.0 IU/LTRAb > 1.0 IU/LTRAb ≤ 1.0 IU/L
n = 21n = 393n = 26n = 542
nRF (%)95% CInRF (%)95% CInRF (%)95% CInRF (%)95% CI
Later hyperthyroid diagnosis1152.429.8-74.3338.45.9-11.6< 5N/AN/A< 5N/AN/A
Later ATD treatment1047.625.7-70.2174.32.5-6.8< 5N/AN/A< 5N/AN/A
Later thyroid surgery or radioiodine treatment< 5N/AN/A51.30.4-2.9< 5N/AN/A< 5N/AN/A
Later pregnancy942.921.8-66.015439.234.3-44.21142.323.4-63.127150.045.7-54.3
 Hyperthyroidism in pregnancy or 2 y post partuma523.88.2-47.2102.51.2-4.6< 5N/AN/A< 5N/AN/A
 ATD in pregnancy or 2 y post partumb523.88.2-47.251.30.4-2.9< 5N/AN/A< 5N/AN/A
Median95% CIMedian95% CI
No. of later ATD prescriptionsc134-2533-7
Median95% CIMedian95% CI
No. of later ATD prescriptionsc134-2533-7

Abbreviations: β-hCG, β-human chorionic gonadotropin; ATD, antithyroid drugs; BMI, body mass index; fT4, free thyroxine; N/A, not available; RF, relative frequency; TRAb, thyrotropin receptor antibodies; TSH, thyrotropin.

aHospital diagnosis of hyperthyroidism while pregnant or 2 years post partum.

bPrescription of ATD in the period from 1 month before pregnancy until 2 years post partum.

cNumber of prescriptions from the first prescription until December 31, 2020.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close